Patents Assigned to Imagilin Technology, LLC
-
Patent number: 11633437Abstract: The present invention provides a method of treating a disease or condition characterized by inflammation in a subject in need thereof, comprising administering to the subject an effective amount of a Pediococcus acidilactici probiotic. Compositions of Pediococcus acidilactici probiotic are also provided.Type: GrantFiled: February 4, 2019Date of Patent: April 25, 2023Assignee: IMAGILIN TECHNOLOGY LLCInventors: Jhy-Jhu Lin, Jolinta Lin
-
Patent number: 10946050Abstract: The present invention provides compositions comprising a probiotc in admixture with an effective amount of an amphipathic substance that enhances viability of the probiotic in the composition when the composition is subjected to heat.Type: GrantFiled: November 30, 2016Date of Patent: March 16, 2021Assignee: IMAGILIN TECHNOLOGY LLCInventors: Jhy-Jhu Lin, Jolinta Lin
-
Publication number: 20190282498Abstract: Compositions wherein foodstuffs act as carriers of freeze-dried probiotics provide new means for administration of probiotics. The products that are easily shipped may be eaten as purchased or mixed with other ingredients to provide variety in the diet while administering beneficial probiotic organisms to the gastrointestinal tract.Type: ApplicationFiled: March 18, 2019Publication date: September 19, 2019Applicant: IMAGILIN TECHNOLOGY, LLCInventor: Jhy-Jhu LIN
-
Patent number: 10195237Abstract: The present invention provides a method of treating a disease or condition characterized by inflammation in a subject in need thereof, comprising administering to the subject an effective amount of a Pediococcus acidilactici probiotic. Compositions of Pediococcus acidilactici probiotic are also provided.Type: GrantFiled: March 16, 2016Date of Patent: February 5, 2019Assignee: IMAGILIN TECHNOLOGY LLCInventors: Jhy-Jhu Lin, Jolinta Lin
-
Patent number: 9789141Abstract: This invention relates to use of probiotics, particularly P acidilactici and S boulardii, for use in conjunction with steroids and other immune suppressor agents to ameliorate symptoms of autoimmune diseases, especially disease symptoms arising from the body's production of antibodies against autologous blood cells. The practice of the invention sustains ameliorative response associated with immune suppressor agents while lowering the amount of immune suppressor agents required for treatment.Type: GrantFiled: May 6, 2016Date of Patent: October 17, 2017Assignee: IMAGILIN TECHNOLOGY, LLCInventors: Jhy-Jhu Lin, Gen Kato, Takuo Ishida
-
Publication number: 20160243173Abstract: This invention relates to use of probiotics, particularly P acidilactici and S boulardii, for use in conjunction with steroids and other immune suppressor agents to ameliorate symptoms of autoimmune diseases, especially disease symptoms arising from the body's production of antibodies against autologous blood cells. The practice of the invention sustains ameliorative response associated with immune suppressor agents while lowering the amount of immune suppressor agents required for treatment.Type: ApplicationFiled: May 6, 2016Publication date: August 25, 2016Applicant: IMAGILIN TECHNOLOGY, LLCInventors: Jhy-Jhu LIN, Gen KATO, Takuo ISHIDA
-
Publication number: 20160193259Abstract: A Pediococcus acidilactici strain that survives incubation for 24 hours at 85° C. and multiplies more than 800 fold after subsequent overnight incubation at 50° C.Type: ApplicationFiled: February 10, 2016Publication date: July 7, 2016Applicant: IMAGILIN TECHNOLOGY, LLC.Inventors: Jhy-Jhu LIN, Susheel Bhanu BUSI
-
Patent number: 9364507Abstract: This invention relates to use of probiotics, particularly P acidilactici and S boulardii, for use in conjunction with steroids and other immune suppressor agents to ameliorate symptoms of autoimmune diseases, especially disease symptoms arising from the body's production of antibodies against autologous blood cells. The practice of the invention sustains ameliorative response associated with immune suppressor agents while lowering the amount of immune suppressor agents required for treatment.Type: GrantFiled: August 11, 2010Date of Patent: June 14, 2016Assignee: IMAGILIN TECHNOLOGY, LLCInventors: Jhy-Jhu Lin, Gen Kato, Takuo Ishida
-
Publication number: 20140193464Abstract: A dry, stable and viable probiotic composition comprising, a probiotic microorganism and a dried plant powder, with the proviso that said composition is not a blended mixture of at least one biologically pure Pediococcus acidilactici probiotic culture and dried tomato powder at a weight ratio of 1:4 encapsulated in an effective amount in a gelatin capsule.Type: ApplicationFiled: January 8, 2013Publication date: July 10, 2014Applicant: IMAGILIN TECHNOLOGY, LLCInventor: Jhy-Jhu Lin
-
Patent number: 8496923Abstract: An exemplary embodiment providing one or more improvements includes feeding animals with probiotic microbes encapsulated in a mixture of xanthan gum and chitosan, or in gelatin, specifically Pediococcus acidilactici and Saccharomyces boulardii. Such encapsulation protects the viability of the probiotic microbes against unfavorable temperatures. An exemplary embodiment providing one or more improvements includes methods of using viable probiotics in therapy of birds and mammals infected with infectious diseases. Probiotics acted as adjuvants in stimulating antibody reaction and stimulated a cellular immunity response. In particular, probiotics were shown to reduce the number of viable oocytes from fecal samples, stimulate antibody production, and stimulate of proliferation of splenocytes in chickens infected with Eimeria. In addition, probiotics were shown to relieve symptoms of parvovirus infection in dogs.Type: GrantFiled: November 2, 2010Date of Patent: July 30, 2013Assignee: Imagilin Technology, LLC.Inventor: Jhy-Jhu Lin
-
Patent number: 8318152Abstract: An exemplary embodiment providing one or more improvements includes probiotic compositions comprising probiotic microorganisms with dried vegetable, fruit, cereal, or herb powder. Feeding human or animals either having biological or environmental changes with probiotic compositions has a positive effect in relieving the changes. Positive effects has been demonstrated in humans, dogs, and fish.Type: GrantFiled: April 16, 2009Date of Patent: November 27, 2012Assignee: Imagilin Technology, LLCInventor: Jhy-Jhu Lin
-
Publication number: 20110129529Abstract: An exemplary embodiment providing one or more improvements includes feeding animals with probiotic microbes encapsulated in a mixture of xanthan gum and chitosan, or in gelatin, specifically Pediococcus acidilactici and Saccharomyces boulardii. Such encapsulation protects the viability of the probiotic microbes against unfavorable temperatures. An exemplary embodiment providing one or more improvements includes methods of using viable probiotics in therapy of birds and mammals infected with infectious diseases. Probiotics acted as adjuvants in stimulating antibody reaction and stimulated a cellular immunity response. In particular, probiotics were shown to reduce the number of viable oocytes from fecal samples, stimulate antibody production, and stimulate of proliferation of splenocytes in chickens infected with Elimeria. In addition, probiotics were shown to relieve symptoms of parvovirus infection in dogs.Type: ApplicationFiled: November 2, 2010Publication date: June 2, 2011Applicant: IMAGILIN TECHNOLOGY LLCInventor: Jhy-Jhu Lin
-
Publication number: 20110129518Abstract: An exemplary embodiment providing one or more improvements includes feeding animals with probiotic microbes encapsulated in a mixture of xanthan gum and chitosan, or in gelatin, specifically Pediococcus acidilactici and Saccharomyces boulardii. Such encapsulation protects the viability of the probiotic microbes against unfavorable temperatures. An exemplary embodiment providing one or more improvements includes methods of using viable probiotics in therapy of birds and mammals infected with infectious diseases. Probiotics acted as adjuvants in stimulating antibody reaction and stimulated a cellular immunity response. In particular, probiotics were shown to reduce the number of viable oocytes from fecal samples, stimulate antibody production, and stimulate of proliferation of splenocytes in chickens infected with Eimeria. In addition, probiotics were shown to relieve symptoms of parvovirus infection in dogs.Type: ApplicationFiled: November 2, 2010Publication date: June 2, 2011Applicant: IMAGILIN TECHNOLOGY LLCInventor: Jhy-Jhu Lin
-
Patent number: 7935334Abstract: An exemplary embodiment providing one or more improvements includes feeding animals with probiotic microbes encapsulated in a mixture of xanthan gum and chitosan, or in gelatin, specifically Pediococcus acidilactici and Saccharomyces boulardii. Such encapsulation protects the viability of the probiotic microbes against unfavorable temperatures. An exemplary embodiment providing one or more improvements includes methods of using viable probiotics in therapy of birds and mammals infected with infectious diseases. Probiotics acted as adjuvants in stimulating antibody reaction and stimulated a cellular immunity response. In particular, probiotics were shown to reduce the number of viable oocytes from fecal samples, stimulate antibody production, and stimulate of proliferation of splenocytes in chickens infected with Elimeria. In addition, probiotics were shown to relieve symptoms of parvovirus infection in dogs.Type: GrantFiled: July 26, 2006Date of Patent: May 3, 2011Assignee: Imagilin Technologies, LLCInventor: Jhy-Jhu Lin
-
Publication number: 20110038838Abstract: Embodiment include methods for treating cats and dogs with inflammatory bowl disease or inflammatory-like bowl disease or immune mediated hemolytic anemia or atopic dermatitis which are being treated with steroids or immune suppressors which involves the step of administering to the animal a probiotic comprised of P. acidilactici and S. boulardii microorganisms for the purpose of reducing the amount of steroid or immune suppressor required to ameliorate the symptoms of the diseases or conditions.Type: ApplicationFiled: August 11, 2010Publication date: February 17, 2011Applicant: IMAGILIN TECHNOLOGY, LLCInventors: Jhy-Jhu Lin, Gen Kato, Takuo Ishida
-
Publication number: 20090263366Abstract: An exemplary embodiment providing one or more improvements includes probiotic compositions comprising probiotic microorganisms with dried vegetable, fruit, cereal, or herb powder. Feeding human or animals either having biological or environmental changes with probiotic compositions has a positive effect in relieving the changes. Positive effects has been demonstrated in humans, dogs, and fish.Type: ApplicationFiled: April 16, 2009Publication date: October 22, 2009Applicant: Imagilin Technology, LLCInventor: Jhy-Jhu Lin